electroCore to Announce Second Quarter Financial Results on Wednesday, August 9
01 août 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
25 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer reviewed...
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
18 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
13 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
electroCore Provides Select Second Quarter 2023 Financial Guidance
11 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary...
gammaCore™ Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms
06 juil. 2023 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its gammaCore non-invasive...
Epilepsy Monitoring Devices Market revenue to cross USD 622 Million by 2035, says Research Nester
06 juil. 2023 05h00 HE
|
Research Nester
New York, July 06, 2023 (GLOBE NEWSWIRE) -- The global epilepsy monitoring devices market is estimated to grow at a CAGR of ~6% from 2023 to 2035. The market is estimated to garner a revenue of...
Rising Prevalence of Chronic Diseases Among People Across the Globe to Propel the Growth of the Global Neuromodulation Devices Market by 2026 – Exclusive Report [150 Pages] By Research Dive
01 déc. 2021 09h00 HE
|
Research Dive
New York, USA, Dec. 01, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global neuromodulation devices market is expected to generate a revenue of $9,332.9 million,...
Vagus Nerve Stimulators Market to Surpass US$ 887.2 Million by 2026 – Coherent Market Insights
28 févr. 2019 08h40 HE
|
CMI
SEATTLE, Feb. 28, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Vagus Nerve Stimulators market size was valued at US$ 445.1 million in 2018, and is projected to exhibit a CAGR...
Neurostimulation Devices Market will achieve 15% CAGR to cross $16 billion by 2024: Global Market Insights, Inc.
12 mars 2018 05h30 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, March 12, 2018 (GLOBE NEWSWIRE) -- Global Neurostimulation Devices Market is poised to surpass USD 16 billion by 2024; according to a new research report by Global Market...